2738 | Humans |
1600 | Female |
1448 | Male |
935 | Middle Aged |
863 | Adult |
842 | Animals |
737 | Aged |
377 | Young Adult |
339 | Adolescent |
335 | Treatment Outcome |
305 | Risk Factors |
273 | Aged, 80 and over |
221 | Child |
210 | Mice |
195 | Mutation |
191 | Time Factors |
185 | Polymorphism, Single Nucleotide |
179 | Prospective Studies |
173 | Genetic Predisposition to Disease |
157 | Follow-Up Studies |
155 | Case-Control Studies |
152 | Prognosis |
149 | Europe |
143 | Child, Preschool |
138 | Genotype |
135 | Cohort Studies |
132 | Genome-Wide Association Study |
129 | Australia |
127 | Breast Neoplasms |
123 | Phenotype |
122 | Infant |
120 | Double-Blind Method |
118 | Phylogeny |
114 | Antineoplastic Combined Chemotherapy Protocols |
113 | Signal Transduction |
110 | Disease-Free Survival |
108 | Retrospective Studies |
99 | Antineoplastic Agents |
98 | Practice Guidelines as Topic |
94 | Incidence |
94 | Age Factors |
91 | Biomarkers |
90 | Survival Rate |
90 | Risk Assessment |
90 | Reproducibility of Results |
90 | Mice, Inbred C57BL |
90 | Ecosystem |
88 | Genetic Variation |
87 | Severity of Illness Index |
87 | Neoplasms |
80 | Surveys and Questionnaires |
79 | Proportional Hazards Models |
79 | Consensus |
77 | Disease Progression |
76 | Disease Models, Animal |
74 | Neoplasm Staging |
74 | Brain |
72 | Pregnancy |
71 | Infant, Newborn |
70 | Sequence Analysis, DNA |
70 | Molecular Sequence Data |
69 | Kaplan-Meier Estimate |
69 | Global Health |
68 | Prevalence |
65 | Risk |
65 | Magnetic Resonance Imaging |
65 | Cross-Sectional Studies |
65 | Biodiversity |
63 | Randomized Controlled Trials as Topic |
63 | France |
63 | Algorithms |
62 | Registries |
61 | European Continental Ancestry Group |
61 | Amino Acid Sequence |
60 | Models, Biological |
59 | Models, Theoretical |
59 | Melanoma |
58 | Societies, Medical |
58 | Muscle, Skeletal |
57 | Gene Expression Profiling |
57 | Evolution, Molecular |
57 | Cardiovascular Diseases |
56 | Ovarian Neoplasms |
56 | Mice, Knockout |
56 | International Cooperation |
56 | Alleles |
55 | Survival Analysis |
55 | Drug Administration Schedule |
54 | Quality of Life |
54 | Odds Ratio |
54 | Genetic Association Studies |
54 | Clinical Trials as Topic |
54 | Cell Line, Tumor |
54 | Biological Evolution |
52 | Drug Therapy, Combination |
51 | Multivariate Analysis |
51 | Gene Expression Regulation |
50 | Stroke |
49 | Predictive Value of Tests |
49 | Pedigree |
49 | Biomarkers, Tumor |
48 | Species Specificity |
48 | Conservation of Natural Resources |
48 | Cells, Cultured |
48 | Body Mass Index |
46 | Protein Kinase Inhibitors |
46 | Longitudinal Studies |
46 | Aging |
45 | United States |
45 | Skin Neoplasms |
45 | Sex Factors |
45 | HIV Infections |
45 | Combined Modality Therapy |
45 | Cell Line |
44 | Terminology as Topic |
44 | Exercise |
43 | Internationality |
43 | Genomics |
43 | Cell Differentiation |
42 | Research Design |
42 | Neoplasm Metastasis |
42 | Dose-Response Relationship, Drug |
41 | Sensitivity and Specificity |
40 | Transcription Factors |
40 | Protein Binding |
40 | Models, Molecular |
40 | Colorectal Neoplasms |
39 | Outcome Assessment (Health Care) |
39 | Neoplasm Recurrence, Local |
39 | Lung Neoplasms |
39 | Diet |
39 | Climate Change |
39 | Chromosome Mapping |
39 | Blood Pressure |
39 | Antibodies, Monoclonal |
38 | Recurrence |
38 | RNA, Messenger |
38 | Quantitative Trait Loci |
38 | Logistic Models |
38 | High-Throughput Nucleotide Sequencing |
38 | Evidence-Based Medicine |
38 | Diabetes Mellitus, Type 2 |
38 | Comorbidity |
38 | Cell Proliferation |
38 | Antiviral Agents |
37 | Seasons |
37 | Rats |
37 | Disease Management |
37 | Anti-Bacterial Agents |
36 | Water |
36 | Intensive Care Units |
36 | Computer Simulation |
36 | Computational Biology |
36 | Biomechanical Phenomena |
35 | Obesity |
35 | Genetic Loci |
35 | Base Sequence |
34 | Temperature |
34 | Prostatic Neoplasms |
34 | DNA Mutational Analysis |
34 | Antibodies, Monoclonal, Humanized |
33 | Transcriptome |
33 | Plant Leaves |
32 | Immunohistochemistry |
32 | Gene Expression Regulation, Neoplastic |
32 | Databases, Factual |
31 | Mice, Transgenic |
31 | Genome, Human |
31 | Gene Expression |
31 | Critical Illness |
31 | Carbon Dioxide |
30 | Models, Statistical |
30 | Gene Frequency |
30 | Coral Reefs |
29 | Vaccination |
29 | Recombinant Proteins |
29 | Pyrimidines |
29 | Mutation, Missense |
29 | Membrane Proteins |
29 | Imidazoles |
29 | Host-Pathogen Interactions |
29 | Haplotypes |
29 | Feeding Behavior |
29 | Exome |
29 | Climate |
29 | Blood Glucose |
29 | Alzheimer Disease |
28 | Software |
28 | Heterozygote |
28 | Heart Failure |
28 | Fishes |
28 | Bayes Theorem |
28 | Age of Onset |
27 | Tomography, X-Ray Computed |
27 | Sulfonamides |
27 | Smoking |
27 | Receptor, ErbB-2 |
27 | Protein Transport |
27 | Plant Proteins |
27 | Macrophages |
27 | Inflammation |
27 | HEK293 Cells |
27 | Environment |
27 | Drug Resistance, Neoplasm |
27 | DNA Methylation |
27 | Chronic Disease |
27 | Chemotherapy, Adjuvant |
27 | Cattle |
27 | Administration, Oral |
27 | Adaptation, Physiological |
26 | Proteins |
26 | Myocardial Infarction |
26 | Intellectual Disability |
26 | Hepacivirus |
26 | Hematopoietic Stem Cell Transplantation |
26 | Guidelines as Topic |
26 | Gene Expression Regulation, Plant |
26 | Arthritis, Rheumatoid |
25 | T-Lymphocytes |
25 | Stress, Physiological |
25 | Real-Time Polymerase Chain Reaction |
25 | Positron-Emission Tomography |
25 | Medical Oncology |
25 | Life Style |
25 | Hospitalization |
25 | Flow Cytometry |
25 | Apoptosis |
24 | United Kingdom |
24 | Reproduction |
24 | Phosphorylation |
24 | Neoplasm Grading |
24 | Models, Genetic |
24 | Hypertension |
24 | Hepatitis C, Chronic |
24 | Heart Rate |
24 | Equipment Design |
24 | Electromyography |
24 | Cell Survival |
24 | Cause of Death |
24 | Body Weight |
23 | Viral Load |
23 | Tuberculosis |
23 | Trees |
23 | Socioeconomic Factors |
23 | Respiration, Artificial |
23 | Oxygen Consumption |
23 | Neuropsychological Tests |
23 | Liver Neoplasms |
23 | Hospital Mortality |
23 | Genome, Plant |
23 | Genetics, Population |
23 | Genetic Testing |
23 | Exercise Test |
23 | DNA-Binding Proteins |
23 | Cytokines |
23 | Cognition |
23 | Cluster Analysis |
23 | Carbon |
23 | Asthma |
22 | Protein Conformation |
22 | Plasmodium falciparum |
22 | Oceans and Seas |
22 | Mitochondria |
22 | Lung |
22 | Liver |
22 | Fossils |
22 | Epigenesis, Genetic |
22 | Dementia |
22 | Cognition Disorders |
22 | Cholesterol |
22 | Athletic Performance |
22 | Arabidopsis |
21 | Soil |
21 | Sequence Alignment |
21 | Remission Induction |
21 | Regression Analysis |
21 | Receptors, Estrogen |
21 | RNA, Viral |
21 | Promoter Regions, Genetic |
21 | Postoperative Complications |
21 | Population Dynamics |
21 | Pilot Projects |
21 | Peptides |
21 | New Zealand |
21 | Muscle Contraction |
21 | Molecular Targeted Therapy |
21 | Linear Models |
21 | Energy Metabolism |
21 | Electrocardiography |
21 | DNA, Mitochondrial |
21 | Biomass |
21 | Binding Sites |
21 | Behavior, Animal |
21 | Adenocarcinoma |
21 | Acute Disease |
20 | Transcription, Genetic |
20 | Proteomics |
20 | Prosthesis Design |
20 | Polymerase Chain Reaction |
20 | Observer Variation |
20 | North America |
20 | Multiple Myeloma |
20 | Insulin |
20 | Hypoglycemic Agents |
20 | Hypertension, Pulmonary |
20 | Hydrogen-Ion Concentration |
20 | Germ-Line Mutation |
20 | Developing Countries |
20 | Depression |
20 | Cooperative Behavior |
20 | Cerebral Hemorrhage |
20 | Biomedical Research |
20 | Athletes |
20 | Analysis of Variance |
19 | Zebrafish |
19 | Tumor Necrosis Factor-alpha |
19 | Stress, Psychological |
19 | Sports |
19 | Reverse Transcriptase Polymerase Chain Reaction |
19 | Polyethylene Glycols |
19 | Photosynthesis |
19 | Patient Selection |
19 | Neurons |
19 | Meta-Analysis as Topic |
19 | Geography |
19 | Genetic Markers |
19 | Enzyme-Linked Immunosorbent Assay |
19 | Databases, Genetic |
19 | DNA |
19 | Coronary Artery Disease |
19 | Carrier Proteins |
19 | Brain Ischemia |
19 | Blotting, Western |
19 | Bacteria |
19 | Asian Continental Ancestry Group |
18 | Water Pollutants, Chemical |
18 | Running |
18 | Ribavirin |
18 | Radiopharmaceuticals |
18 | Predatory Behavior |
18 | Phylogeography |
18 | Organ Size |
18 | Movement |
18 | Molecular Sequence Annotation |
18 | Lymphocyte Activation |
18 | Liver Cirrhosis |
18 | Kidney Neoplasms |
18 | Immunosuppressive Agents |
18 | Image Processing, Computer-Assisted |
18 | Health Services Accessibility |
18 | Health Knowledge, Attitudes, Practice |
18 | Elasticity Imaging Techniques |
18 | Critical Care |
18 | Cost-Benefit Analysis |
18 | Cholesterol, LDL |
18 | Biopsy |
18 | Bacterial Proteins |
18 | Animal Distribution |
18 | Angiogenesis Inhibitors |
18 | Agriculture |
17 | Tumor Suppressor Proteins |
17 | Stroke Volume |
17 | Seawater |
17 | Repressor Proteins |
17 | Pyridines |
17 | Protozoan Proteins |
17 | Postmenopause |
17 | Plant Roots |
17 | Oxygen |
17 | Nitrogen |
17 | Mice, Inbred BALB C |
17 | Malaria |
17 | Kinetics |
17 | Killer Cells, Natural |
17 | Indoles |
17 | Immunity, Innate |
17 | Gene Expression Regulation, Developmental |
17 | Erythrocytes |
17 | Environmental Monitoring |
17 | Drug Combinations |
17 | Droughts |
17 | Carcinoma, Renal Cell |
17 | Brain Neoplasms |
17 | Body Size |
17 | Atrial Fibrillation |
17 | Anthozoa |
17 | Age Distribution |
16 | Up-Regulation |
16 | Swine |
16 | Sex Distribution |
16 | Sex Characteristics |
16 | Selection, Genetic |
16 | Reference Values |
16 | ROC Curve |
16 | Psychomotor Performance |
16 | Psychometrics |
16 | Precision Medicine |
16 | Plants |
16 | Oxidative Stress |
16 | Occupational Exposure |
16 | Nuclear Proteins |
16 | Neoplasm Invasiveness |
16 | Myalgia |
16 | Muscle Strength |
16 | Motor Activity |
16 | Mortality |
16 | Microbial Sensitivity Tests |
16 | Metabolic Syndrome X |
16 | Mass Screening |
16 | Lipids |
16 | Kidney |
16 | Immunotherapy |
16 | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
16 | History, Ancient |
16 | DNA Copy Number Variations |
16 | Crystallography, X-Ray |
16 | Clinical Trials, Phase III as Topic |
16 | Cholesterol, HDL |
16 | Ants |
16 | Africa |
16 | Adaptor Proteins, Signal Transducing |
15 | Water Purification |
15 | Ventricular Function, Left |
15 | Triazoles |
15 | Structure-Activity Relationship |
15 | Stents |
15 | Social Behavior |
15 | Sheep |
15 | Sepsis |
15 | Rats, Wistar |
15 | Pyrazoles |
15 | Prostatic Neoplasms, Castration-Resistant |
15 | Percutaneous Coronary Intervention |
15 | Papillomavirus Infections |
15 | Pain Measurement |
15 | Paclitaxel |
15 | Nerve Tissue Proteins |
15 | Neoplasms, Glandular and Epithelial |
15 | Monte Carlo Method |
15 | MCF-7 Cells |
15 | Light |
15 | Isometric Contraction |
15 | Injections, Subcutaneous |
15 | Immunoglobulin G |
15 | Imaging, Three-Dimensional |
15 | Homeodomain Proteins |
15 | Hemodynamics |
15 | Genome |
15 | Forecasting |
15 | Fatigue |
15 | Exons |
15 | Epilepsy |
15 | Drug Discovery |
15 | Disease Outbreaks |
15 | Diagnosis, Differential |
15 | Delphi Technique |
15 | Congresses as Topic |
15 | Cell Nucleus |
15 | Cell Adhesion |
15 | Calcium |
15 | Bone Neoplasms |
15 | Bicycling |
15 | BRCA1 Protein |
15 | Asia |
15 | Anticholesteremic Agents |
14 | World Health Organization |
14 | Statistics as Topic |
14 | Sequence Analysis, RNA |
14 | Recombinant Fusion Proteins |
14 | Receptors, Progesterone |
14 | Reactive Oxygen Species |
14 | Rats, Sprague-Dawley |
14 | Pyrroles |
14 | Proto-Oncogene Proteins B-raf |
14 | Polymorphism, Genetic |
14 | Plant Diseases |
14 | Pancreatic Neoplasms |
14 | Pain |
14 | Netherlands |
14 | Microsatellite Repeats |
14 | Mass Spectrometry |
14 | Malaria, Falciparum |
14 | Larva |
14 | Internet |
14 | Interferon-alpha |
14 | Insect Proteins |
14 | Influenza, Human |
14 | Homeostasis |
14 | Hemorrhage |
14 | Health Policy |
14 | HeLa Cells |
14 | Glucose |
14 | Genome, Viral |
14 | Estrogen Receptor alpha |
14 | Endometrial Neoplasms |
14 | Electroencephalography |
14 | Echocardiography |
14 | Early Detection of Cancer |
14 | Dendritic Cells |
14 | Carbon Cycle |